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Abstract 
Background and aims: The Rome IV criteria define functional gastrointestinal (GI) disorders by 
specific combinations of symptoms. It is possible to empirically evaluate these symptom 
combinations by factor analysis (a statistical procedure that groups variables that correlate). 
However, this analysis has not been performed for the Rome IV criteria, and factor analyses based on 
the previous versions of the Rome criteria did not use population-based data. We therefore 
investigated symptom grouping by the Rome IV questionnaire using factor analysis of a population-
based sample. 
Methods: The Rome IV questionnaire was completed online in English by 5931 respondents from the 
United Kingdom, United States, and Canada (49% female, age range, 18–92 years). We performed an 
exploratory factor analysis on the Rome IV questions. Next, we performed a confirmatory factor 
analysis to compare the exploratory factor result to that of the Rome IV criteria. 
Results: The exploratory factor analysis identified 8 factors that accounted for 45% of the variance in 
response: constipation, diarrhea, irritable bowel syndrome, abdominal pain, heartburn, nausea or 
vomiting, globus, and other upper GI symptoms. Most factors corresponded to distinct functional GI 
disorders defined by the Rome IV criteria—exceptions included abdominal pain and upper GI 
symptoms. In confirmatory factor analysis, the exploratory model fitted slightly better than that 
based on the Rome IV criteria (root mean square error of approximation, 0.063 vs 0.077). 
Conclusion: We used factor analysis to identify distinct upper and lower GI symptom groups that are 
compatible with the Rome IV criteria. Our findings support the use of the Rome IV criteria in research 
and clinical practice as a basis for development of diagnostics and management of patients. 
Keywords: IBS; FGID; validation; internet survey   
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Introduction 
Functional gastrointestinal (GI) disorders (FGIDs) are syndromes defined by clusters of symptoms 
emanating from the GI tract, with population prevalences for many of these disorders ranging 
between 5 and 10%.
1
 More than 20 FGIDs are defined by the published Rome IV criteria,
2
 based on 
specific GI symptom combinations. 
The distinction of each FGID as a separate entity may be corroborated by investigating how GI 
symptoms group together in the general population, and whether these symptom groupings are 
compatible with the Rome criteria. One method of doing so is factor analysis: a statistical procedure 
that groups variables with strong inter-correlations. Consistent agreement between factor analysis 
and the Rome symptom criteria would then suggest that the disorders represent distinct entities 
which are identified by these symptom criteria. Previous studies have performed factor analyses on 
GI symptoms, and compared the resulting factors to the structures of the Rome I and II criteria,
3,4
 as 
well as the Manning criteria for irritable bowel syndrome (IBS).
5
 For example, Whitehead et al
6
 found 
factors of IBS (i.e. abdominal pain related to stool patterns), nausea, constipation (including straining 
and incomplete evacuation), and a heterogeneous group of other GI symptoms. A similar IBS factor 
was found by Taub et al
7
 and Talley et al.
8
 Whitehead et al
9
 performed a factor analysis on GI 
symptoms in gastroenterology clinic patients, and reported thirteen distinct factors, including IBS, 
constipation, diarrhoea, and anorectal pain, but also several upper GI factors. Finally, Siah et al
10
 
described amongst others a factor of bloating, associated with flatulence and belching. In conclusion, 
factor analyses can be used to substantiate the definitions of FGIDs. 
The above factor analyses assessed Rome I, II, and III diagnostic classifications, but such analyses 
have not been performed since the publication of Rome IV. Furthermore, most of the previous factor 
analyses did not use population-based samples. We therefore aimed to empirically substantiate the 
latest definitions of FGIDs in a large, population-based sample by factor analysis. 
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Methods 
 
Rome IV survey 
We used an internet-based Rome IV survey involving 6300 individuals, with methodology described 
previously.
1
 Briefly, participants were a nationally representative adult population sample from the 
United States (US), United Kingdom (UK), and Canada, as selected by the survey vendor Qualtrics Inc. 
Quota-based sampling was used to ensure equal proportion of sex (50:50), age groups (40% aged 18-
39, 40% aged 40-64, and 20% aged 65 and older), and education level (30% maximum with more 
than sixteen years of formal education) across the countries. In the US sample, the survey vendor 
also selected 20% African Americans and 20% Hispanic ethnicity respondents, but these demographic 
shifts were not done in the UK or Canada. The survey was presented as a health survey without 
specific mention of gastroenterology, in order to prevent enrichment of participants with GI 
problems. All respondents confirmed informed consent online at the start of the survey. To ensure 
reporting quality, three questions were presented twice, and there were two attention verification 
questions. The survey was completed by a total of 6300 respondents, i.e. 2100 for the US, UK, and 
Canada respectively. Before data collection started, the study was reviewed by the Institutional 
Review Board (IRB) at the University of North Carolina and deemed IRB-exempt as all study 
participants were anonymous to the investigators. 
 
Data pre-processing 
Of the 6300 respondents, we included those who satisfied both attention verification questions and 
the response consistency checks with the three repeated symptom questions. This left 5931 
respondents in the analysis sample. Of the 86 Rome IV questions, we included those with ordinal 
response scales, as these can be used to compute correlations. Excluded questions mostly related to 
the length of time the symptom had been present. No questions critical to a Rome IV FGID diagnosis 
were excluded. A total of 49 Rome IV questions were included in the analysis. 
 
Exploratory factor analysis 
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We performed an exploratory factor analysis using the "factanal" function in R version 3.3.3.
11
 This is 
a statistical procedure that groups variables with strong inter-correlations, and as such identifies the 
key variable groupings. A correlation matrix of the Rome IV questions was computed, and orthogonal 
factors with an eigenvalue larger than 1 were retained. Factor analysis was performed with 
maximum likelihood estimation and varimax rotation. Loadings of 0.40 and larger were deemed 
relevant. 
 
Confirmatory factor analysis 
We used confirmatory factor analysis to confirm that Rome IV successfully captures the GI symptoms 
into distinct FGID entities. This is done by fitting a pre-specified model of the Rome IV structure, and 
comparing this model to the data-driven structure resulting from the exploratory factor analysis. In 
case the models are similar of composition and statistical fit, this further reinforces the Rome IV 
criteria. 
The factor structure of the Rome IV criteria was pre-specified as follows (see table 1 for reference). 
Globus was defined as a lump in the throat occurring between meals (items 1 and 3). Functional 
heartburn was defined by burning sensations in the chest (items 7 and 9). Functional dysphagia was 
defined by foods sticking in the oesophagus
12
 (items 8 and 12). Postprandial distress syndrome was 
defined by postprandial fullness and early satiety (items 14 and 16). Chronic nausea and vomiting 
syndrome was defined by nausea and vomiting
13
 (items 21 and 23). IBS was defined by pain 
anywhere in the abdomen related to defecation (items 40, 41, 42, and 43). Functional constipation 
was defined by stools that are hard, infrequent, and hard to pass
14
 (items 49, 51, 52, 53, 54, and 55). 
Biliary pain was defined by pain in the right upper quadrant
15
 (items 68, 69, 70, 71, and 72). Other 
FGIDs were defined by only one eligible Rome IV question, and were not in the confirmatory model 
in order to be consistent with the exploratory model. The exploratory and Rome IV based models 
were compared by root mean square error of approximation (RMSEA). 
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Results 
There were 5931 respondents in the analysis sample. The demographics approximated those from 
recent census reports
16-18
 by age and sex categories. The age ranged from 18 to 92 years old and 49% 
was female (figure 1). Common FGIDs were: functional dyspepsia, postprandial distress syndrome: 
7.7%; functional constipation: 6.3%; proctalgia fugax: 5.9%; IBS: 5.7%; functional abdominal 
bloating/distension: 5.6%; functional diarrhoea: 5.4%. 
 
Exploratory factor analysis 
Eight distinct factors emerged from the factor analysis, and were characterised as constipation, 
diarrhoea, IBS, abdominal pain, heartburn, nausea/vomiting, globus, and other upper GI symptoms 
(table 1). Taken together, they explained 45% of the response variance. The constipation factor held 
all items that define functional constipation in Rome IV. Diarrhoea was described by loose stools, 
including those after a meal, as well as urgency, and was thus compatible with functional diarrhoea 
in Rome IV. The IBS factor held the Rome IV defining questions for IBS (abdominal pain related to 
defecation, stool frequency, and stool consistency) with large loadings (r >= 0.73), but also pain in the 
epigastric or right upper quadrant regions related to defecation, albeit with smaller loadings (r = 0.45 
and 0.48). In the factor of abdominal pain, pain was not associated with defecation but did interfere 
with usual activities, i.e. symptoms partially covering both biliary pain
15
 and centrally mediated 
abdominal pain syndrome in Rome IV.
19
 Heartburn and globus overlapped with the Rome IV 
definitions for functional heartburn and globus. The factor nausea/vomiting contained the items 
used to define chronic nausea and vomiting syndrome in Rome IV, plus retching and vomiting related 
to right upper quadrant pain (r = 0.58 and 0.63). Finally, there was a factor of upper GI symptoms, 
containing two symptoms of functional dyspepsia in Rome IV (epigastric pain and postprandial 
fullness), but also bloating, belching, abdominal pain, and some oesophageal symptoms. Some items 
stood in isolation, particularly pain with swallowing, early satiety, abdominal pain related to a meal, 
faecal incontinence, and anorectal pain (r < 0.40). All items and their rotated factor loadings are 
shown in table 1. Results separate for the three country samples are available in supplementary 
information (supplementary tables 1-3). 
Of the 5931 respondents, 62% met the Rome IV symptom threshold for at least one single symptom 
that is part of the definition of FGIDs (figure 2). Symptoms were sometimes confined to one factor 
(19%), but often covered items from two (11%) or more (32%), indicating a degree of overlap 
between the various GI symptoms. The most common symptom was abdominal pain related to 
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defecation (21%) followed by bloating/abdominal distension and loose stools (19% each), whereas 
no oesophageal or gastroduodenal symptom was particularly common (maximum 10%). 
As can be appreciated in figure 2, the IBS factor had the strongest within-factor loadings and 
correlations: of the 30% who met the Rome IV symptom threshold for at least one of the items in the 
IBS factor, 77% met the criteria for at least two items (note the contrasting black and white colour 
patterns for IBS in figure 2). By contrast, of the 33% who met the Rome IV symptom threshold for at 
least one upper GI item, only 51% met the criteria for at least two. Many upper GI items thus stood in 
isolation, possibly because many upper GI FGIDs are based on a single key symptom rather than a 
combination of symptoms, unlike most functional bowel disorders. 
 
Confirmatory factor analysis 
The exploratory factor model had a slightly better fit than that of the Rome IV model (RMSEA: 0.063 
vs. 0.077, chi-square: 17500 vs. 8932, df: 712 vs. 247). However, the difference in fit was small, also 
given that the most factors and FGIDs were represented in both the exploratory and Rome IV model, 
with near-identical compositions (figure 3). As can be seen in figure 3, the confirmatory model had 
coefficients of a magnitude comparable to those of the exploratory model (these are the values on 
the diagonal lines: compare left versus right). One item had a negative coefficient in the confirmatory 
model: right upper quadrant pain at different intervals (item 71, -0.16, figure 3), indicating that it did 
not match well with the factor for biliary pain as hypothesised based on Rome IV. 
 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Discussion  
The present study empirically evaluated the symptom combinations in the Rome IV criteria, and 
found eight distinct symptom groupings, these being constipation, diarrhoea, IBS, abdominal pain, 
heartburn, nausea/vomiting, globus, and other upper GI symptoms. All in all these corresponded well 
with the Rome IV structure.
2
 
The factors for IBS, constipation, diarrhoea, globus, heartburn, and nausea/vomiting closely matched 
the Rome IV criteria for IBS, functional constipation, functional diarrhoea,
14
 globus, functional 
heartburn,
12
 and chronic nausea and vomiting syndrome
13
 respectively, thereby reinforcing the Rome 
IV criteria for these FGIDs. Moreover, these factors were quite similar to those reported in factor 
analyses of earlier Rome editions.
6-10
 The IBS factor was the most distinct, with respondents scoring 
either very high or very low on all defining questions.  While constipation and diarrhoea are often 
seen in IBS patients, IBS is a heterogeneous condition, and as such it is not unexpected to see factors 
for the core element of IBS (pain related to stool patterns) as well as for the separate stool patterns. 
We found a separate factor for abdominal pain, i.e. of a different nature than IBS, which also has 
been described in earlier studies.
9
 It covered both items from biliary pain (right upper quadrant 
pain)
15
 and centrally mediated abdominal pain syndrome (pain restricting usual activities).
19
 This 
factor does not cleanly represent biliary pain, as the item of the pain taking place at different 
intervals loaded negatively on this factor, while being a defining item in Rome IV. Instead it may 
represent centrally mediated abdominal pain syndrome, in which the pain is nearly continuously 
present. Nevertheless, it is difficult for respondents to sense exactly where the pain is located 
(possibly due to diffuse activation of nociceptive systems in visceral organs),
20
 explaining the overlap 
between pains in the various abdominal sub-regions. Moreover, irrespective of factor structure, it is 
possible that symptoms overlap between different disorders due to common pathophysiological 
mechanisms. 
Upper GI symptoms factored into heartburn, globus, and nausea/vomiting. There was also a factor 
with a combination of upper GI symptoms including functional dyspepsia and overlapping symptoms 
such as belching and bloating, which was also found by Siah et al.
10
 Whitehead et al
9
 reported 
separate factors of heartburn, dysphagia, globus, rumination syndrome, and dyspepsia, capturing the 
structure proposed in Rome I. Others saw factors of nausea and gas/belching/acid
6,7
 or reflux.
8
 Factor 
analyses have also been performed on different questionnaires, such as the reflux disease 
questionnaire, where factors were found for regurgitation (e.g. acid taste), heartburn, and dyspepsia, 
although upper GI symptoms overlapped considerably,
21
 in line with the present study. Siah et al
10
 
further discussed a meal-related factor. Meal-related abdominal pain in the present study did not 
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load on any factor, with the largest loadings being for IBS (r = 0.38) and abdominal pain (r = 0.33). 
The existence of a broad factor of upper GI symptoms may imply a degree of common 
pathophysiology between these items. Common mechanisms may be peripheral or central. For 
example, Fischler et al
22
 found a factor of bloating and postprandial fullness to be associated with 
delayed gastric emptying, a factor of belching associated with gastric hypersensitivity, and a factor of 
epigastric pain associated with both gastric hypersensitivity and several psychosocial factors. In 
summary, the factor structure of upper GI symptoms found in the present study is quite consistent 
with those of prior studies, and partially reinforces the Rome IV criteria, although some upper GI 
symptoms were difficult to separate out using the Rome IV questionnaire. 
Finally, confirmatory factor analysis showed that Rome IV groups symptoms in a manner that 
captures the variance in the population, close to the factors found through computerised means (i.e. 
the exploratory factor analysis). The item "right upper quadrant pain at different intervals", defining 
biliary pain in Rome IV, was the only odd one out to have a negative coefficient for this FGID. It may 
be considered to rephrase this item in future Rome editions.  
Our study has two strengths. First, while factor analytical studies have contributed to amendments of 
Rome I, we present a factor analysis for the published Rome IV questionnaire. The results reinforce 
the Rome IV criteria, which can be used in research and clinical care for diagnostics and specific 
management of FGID patients. Second, we did so in a large sample in three countries, with 
demographics close to those of the general population. Generalisability of our findings to the 
population should therefore be high. It remains to be seen whether other languages, countries, or 
continents (e.g. Asia) would render similar findings,
23
 although the recent factor analysis by Siah et 
al
10
 of Rome III shows that any differences are likely to be subtle. A limitation is the absence of 
information on how many potential respondents chose to ignore the invitation to partake in the 
survey, despite the close similarity between sample and population demographics. Furthermore, 
some FGIDs are described by only one key symptom in Rome IV, so that these will not be supported 
by factor analysis. However, it is useful to include these symptoms into the exploratory analysis to 
determine whether there are unpredicted symptom associations that should be recognised. 
To conclude, upper and lower GI symptom groupings compatible with Rome IV diagnoses exist in the 
general population, and can be identified using the English Rome IV questionnaire in a large 
population-based sample from three English-speaking countries. Our results provide further basis for 
practising clinicians to use the Rome IV criteria throughout the process going from symptoms to 
diagnosis and management. While our results reinforce the Rome IV criteria, some upper GI 
symptoms were difficult to separate out, and more work is needed to reach a distinct classification. 
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Figure captions 
Figure 1: Age and sex of the respondents in the present study (bars) compared to those of recent 
census reports (shade). 
Figure 2: Raw data. Columns are Rome IV questions sorted numerically by factor. Rows are 
respondents, sorted by the number of factors with items meeting the Rome IV symptom threshold. 
Darker colours represent higher (worse) responses. 
Figure 3: Schematic overview of the exploratory (left) and confirmatory (right) factor models. Ovals 
are factors, rectangles are Rome IV items. Values on diagonal lines are standardised coefficients 
(factor loadings), and indicate how strongly each item loads on the factor that it defines. Values on 
vertical lines denote covariances of factors. Values in boxes are error terms. 
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Table 1: Factor loadings after varimax rotation. 
Item Topic C
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G
lo
b
u
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1 Lump in throat .15 .36 .03 .02 .12 .08 .08 .78 
3 Lump in throat when not eating .09 .05 .19 .14 .08 .04 .19 .48 
4 Pain with swallowing .12 .17 .23 .08 .22 .03 .30 .07 
5 Chest pain .20 .49 .10 -.01 .18 .08 .22 .18 
7 Chest pain as burning sensation .07 .12 .19 .13 .05 .05 .62 .07 
8 Chest pain and food sticking after swallowing .09 .10 .08 .12 .18 .05 .45 .09 
9 Heartburn .15 .41 .07 .05 .11 .12 .49 .08 
12 Foods stuck in chest .18 .43 .05 .03 .20 .11 .33 .22 
14 Postprandial fullness .18 .41 .18 .04 .25 .13 .21 .08 
16 Early satiety .22 .36 .17 .05 .30 .13 .15 .09 
18 Epigastric pain/burning .15 .55 .29 .03 .25 .09 .26 .04 
19 Epigastric pain/burning improved by defecation .12 .03 -.05 .45 -.02 .00 .21 .10 
21 Nausea .16 .38 .29 .08 .54 .11 .11 .07 
23 Vomiting .11 .27 .15 .05 .66 .07 .10 .05 
25 Self-induced vomiting .06 .00 -.01 .00 .17 .09 .18 .07 
32 Food coming back up after swallowing .16 .44 .07 .08 .37 .12 .21 .12 
34 Retching .14 .14 .16 .07 .58 .14 .15 .09 
35 Vomiting when food comes back up .20 .15 .21 .09 .63 .13 .09 .01 
37 Food coming back up is recognisable .04 .10 .11 .12 .18 -.01 .05 .06 
38 Belching .09 .40 .15 .04 .27 .10 .19 .05 
40 Pain anywhere in the abdomen .25 .63 .33 .11 .13 .18 .02 .05 
41 Abdominal pain related to defecation .14 .03 .06 .73 -.01 .13 .03 .01 
42 Abdominal pain related to stool consistency .20 .07 .11 .85 .08 .19 .05 .04 
43 Abdominal pain related to stool frequency .22 .08 .16 .75 .13 .23 .10 .03 
45 Abdominal pain related to a meal .09 .13 .33 .38 .13 .25 .22 .04 
46 Abdominal pain limits usual activities .17 .14 .54 .27 .24 .16 .10 .05 
49 Hard stools .61 .13 .10 .14 .08 -.03 .12 .07 
51 Infrequent stools .55 .08 .18 .08 .14 .03 .04 .06 
52 Straining during bowel movements .80 .16 .09 .18 .08 .04 .11 .06 
53 Incomplete bowel emptying .72 .19 .13 .20 .12 .20 .09 .06 
54 Anorectal obstruction / blockage .81 .20 .14 .14 .10 .10 .09 .06 
55 Manual manoeuvres to facilitate defecation .52 .14 .13 .05 .11 .04 .10 -.01 
59 Loose stools .07 .21 .09 .21 .15 .73 .08 .03 
61 Loose stools following a meal .03 .05 .17 .21 .09 .64 .11 .06 
63 Urgency .20 .25 .18 .20 .12 .64 .10 .03 
65 Bloating / abdominal distension .37 .42 .20 .15 .03 .27 .07 .08 
68 Right upper quadrant pain .25 .63 .38 .09 .14 .17 .01 .03 
69 Long-lasting right upper quadrant pain .18 .18 .71 .08 .12 .09 .10 .07 
70 Right upper quadrant pain of steady severe level .19 .17 .74 .09 .14 .14 .07 .05 
71 Right upper quadrant pain at different intervals -.07 -.12 -.12 .11 -.10 .01 .03 -.02 
72 Right upper quadrant pain limits usual activities .12 .19 .63 .07 .26 .07 .07 .04 
73 Right upper quadrant pain related to defecation .17 .07 .13 .48 .05 .14 .01 .03 
74 Right upper quadrant pain related to posture .10 .02 .08 .13 .09 .06 .15 .00 
75 Right upper quadrant pain improved by medicine .05 .08 .04 .01 .05 .05 .42 -.01 
76 Right upper quadrant pain related to vomiting .11 .16 .37 .05 .57 .10 .17 .04 
77 Right upper quadrant pain related to back pain .18 .21 .40 .07 .14 .07 .17 .05 
78 Right upper quadrant pain waking one up .13 .25 .51 .04 .26 .15 .15 .00 
80 Faecal incontinence .11 .28 .07 .09 .13 .36 .05 .01 
83 Anorectal pain .38 .38 .13 .12 .11 .17 .02 .04 
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Supplementary material 
This supporting document presents exploratory factor analysis results separate for the three countries. 
Methods are identical to those described in the main text. 
Results are presented in supplementary tables 1-3. Briefly, factors were highly similar across the individual 
countries. There emerged factors for IBS, constipation, diarrhoea, abdominal pain, nausea and/or vomiting, 
and upper GI symptoms in all models. Heartburn and globus were part of the upper GI symptom factor in 
the US sample. 
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Supplementary table 1: Factor loadings in US sample after varimax rotation. 
Item Topic U
p
p
e
r 
G
I 
A
b
d
o
m
in
a
l 
p
a
in
 
C
o
n
st
ip
a
ti
o
n
 
U
p
p
e
r 
G
I 
II
 
N
a
u
se
a
/v
o
m
it
in
g
 
IB
S
 
D
ia
rr
h
o
e
a
 
  
1 Lump in throat .54 .11 .19 .17 .11 .00 .08   
3 Lump in throat when not eating .33 .20 .14 .49 .10 .07 -.02   
4 Pain with swallowing .34 .33 .15 .27 .20 .07 .02   
5 Chest pain .59 .21 .22 .05 .13 .01 .12   
7 Chest pain as burning sensation .49 .17 .12 .28 .07 .22 .06   
8 Chest pain and food sticking after swallowing .40 .08 .11 .39 .18 .17 .00   
9 Heartburn .61 .09 .15 .12 .08 .13 .11   
12 Foods stuck in chest .63 .14 .16 .19 .16 .04 .10   
14 Postprandial fullness .46 .26 .22 .05 .23 -.02 .16   
16 Early satiety .40 .24 .27 .02 .28 .04 .17   
18 Epigastric pain/burning .60 .37 .17 .02 .24 .03 .13   
19 Epigastric pain/burning improved by defecation .08 .01 .13 .59 -.04 .37 .03   
21 Nausea .42 .31 .21 .03 .58 .08 .15   
23 Vomiting .42 .18 .13 .07 .66 .05 .08   
25 Self-induced vomiting .20 .05 .10 .54 .26 .02 .04   
32 Food coming back up after swallowing .59 .11 .14 .17 .33 .09 .14   
34 Retching .30 .24 .12 .33 .55 .12 .16   
35 Vomiting when food comes back up .22 .33 .21 .11 .62 .17 .10   
37 Food coming back up is recognisable .13 .19 .05 .50 .24 .11 .01   
38 Belching .49 .19 .13 .22 .25 .01 .12   
40 Pain anywhere in the abdomen .56 .44 .26 -.10 .13 .12 .20   
41 Abdominal pain related to defecation .02 .04 .18 .33 .00 .68 .16   
42 Abdominal pain related to stool consistency .08 .09 .23 .16 .11 .85 .15   
43 Abdominal pain related to stool frequency .13 .19 .25 .14 .12 .74 .20   
45 Abdominal pain related to a meal .25 .35 .15 .21 .14 .36 .22   
46 Abdominal pain limits usual activities .14 .59 .23 .00 .28 .24 .19   
49 Hard stools .21 .15 .56 .14 .11 .12 -.06   
51 Infrequent stools .13 .17 .55 .12 .12 .12 .04   
52 Straining during bowel movements .22 .09 .80 .09 .05 .23 .07   
53 Incomplete bowel emptying .25 .14 .72 .05 .11 .24 .21   
54 Anorectal obstruction / blockage .23 .20 .79 .07 .12 .14 .11   
55 Manual manoeuvres to facilitate defecation .20 .23 .46 .22 .15 .02 .02   
59 Loose stools .29 .08 .08 .10 .15 .23 .75   
61 Loose stools following a meal .16 .20 .03 .22 .11 .20 .64   
63 Urgency .32 .19 .22 .15 .10 .18 .62   
65 Bloating / abdominal distension .39 .25 .41 -.03 .04 .14 .29   
68 Right upper quadrant pain .55 .49 .24 -.11 .15 .14 .20   
69 Long-lasting right upper quadrant pain .28 .67 .24 .03 .12 .10 .08   
70 Right upper quadrant pain of steady severe level .23 .69 .24 .10 .13 .10 .15   
71 Right upper quadrant pain at different intervals -.09 -.09 -.06 .32 -.06 .04 .08   
72 Right upper quadrant pain limits usual activities .17 .68 .12 .10 .26 .06 .03   
73 Right upper quadrant pain related to defecation .05 .14 .24 .42 .06 .33 .18   
74 Right upper quadrant pain related to posture .06 .08 .08 .29 .06 .06 .09   
75 Right upper quadrant pain improved by medicine .25 .05 .07 .36 -.01 .06 .06   
76 Right upper quadrant pain related to vomiting .30 .36 .14 .25 .59 .04 .11   
77 Right upper quadrant pain related to back pain .31 .44 .20 .28 .08 .02 .03   
78 Right upper quadrant pain waking one up .33 .51 .10 .20 .20 .05 .14   
80 Faecal incontinence .38 .10 .13 .19 .15 .09 .30   
83 Anorectal pain .40 .17 .36 .17 .19 .12 .15   
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Supplementary table 2: Factor loadings in Canadian sample after varimax rotation. 
Item Topic U
p
p
e
r 
G
I 
A
b
d
o
m
in
a
l 
p
a
in
 
C
o
n
st
ip
a
ti
o
n
 
IB
S
 
D
ia
rr
h
o
e
a
 
N
a
u
se
a
/v
o
m
it
in
g
 
G
lo
b
u
s 
  
1 Lump in throat .41 -.03 .13 .04 .06 .07 .43   
3 Lump in throat when not eating .05 .09 .07 .15 .10 .03 .64   
4 Pain with swallowing .20 .12 .09 .12 .03 .05 .11   
5 Chest pain .54 .06 .17 -.02 .07 .09 .21   
7 Chest pain as burning sensation .11 .18 .07 .06 .06 .02 .16   
8 Chest pain and food sticking after swallowing .21 .00 .08 .11 .00 .08 -.08   
9 Heartburn .49 .10 .14 .05 .11 .02 .05   
12 Foods stuck in chest .54 .01 .16 .04 .11 .06 .04   
14 Postprandial fullness .56 .16 .14 .03 .11 .04 -.06   
16 Early satiety .53 .10 .17 .06 .12 .11 -.02   
18 Epigastric pain/burning .58 .34 .14 .05 .07 .03 .04   
19 Epigastric pain/burning improved by defecation .01 -.12 .12 .43 -.01 .06 .17   
21 Nausea .50 .34 .11 .08 .10 .32 .07   
23 Vomiting .33 .26 .10 .04 .04 .48 .06   
25 Self-induced vomiting -.08 .05 .02 -.09 .02 .08 .11   
32 Food coming back up after swallowing .53 .08 .17 .09 .10 .26 .09   
34 Retching .21 .09 .07 .04 .03 .49 .11   
35 Vomiting when food comes back up .17 .16 .18 .02 .14 .76 -.05   
37 Food coming back up is recognisable .12 .01 .01 .06 -.02 .05 .12   
38 Belching .46 .10 .07 .03 .06 .09 -.05   
40 Pain anywhere in the abdomen .52 .41 .24 .07 .19 .03 .15   
41 Abdominal pain related to defecation .01 .09 .14 .73 .16 .02 .08   
42 Abdominal pain related to stool consistency .10 .17 .19 .88 .19 .02 .11   
43 Abdominal pain related to stool frequency .13 .22 .21 .66 .25 .04 .02   
45 Abdominal pain related to a meal .18 .34 .09 .30 .28 -.05 .08   
46 Abdominal pain limits usual activities .23 .53 .18 .17 .17 .10 .05   
49 Hard stools .18 .06 .64 .12 .00 -.03 .09   
51 Infrequent stools .08 .21 .53 .01 .04 .14 .09   
52 Straining during bowel movements .21 .11 .80 .12 .04 .05 .10   
53 Incomplete bowel emptying .22 .22 .71 .16 .17 .11 .02   
54 Anorectal obstruction / blockage .23 .12 .82 .12 .09 .08 .05   
55 Manual manoeuvres to facilitate defecation .11 .14 .56 .07 .01 .04 -.10   
59 Loose stools .19 .15 .04 .12 .74 .08 .07   
61 Loose stools following a meal .06 .11 .00 .16 .66 .00 .14   
63 Urgency .23 .20 .18 .14 .68 .09 -.02   
65 Bloating / abdominal distension .39 .20 .34 .14 .33 -.03 -.03   
68 Right upper quadrant pain .48 .40 .26 .05 .19 .04 .11   
69 Long-lasting right upper quadrant pain .06 .71 .15 .09 .14 .04 .10   
70 Right upper quadrant pain of steady severe level .12 .75 .17 .13 .17 .01 .02   
71 Right upper quadrant pain at different intervals -.12 -.14 -.08 .07 -.02 -.05 .02   
72 Right upper quadrant pain limits usual activities .14 .69 .13 .09 .08 .13 .04   
73 Right upper quadrant pain related to defecation .06 .14 .16 .58 .16 .06 .02   
74 Right upper quadrant pain related to posture .12 .07 -.01 .10 .01 .08 -.03   
75 Right upper quadrant pain improved by medicine .15 .06 .05 .02 .02 .07 -.06   
76 Right upper quadrant pain related to vomiting .16 .49 .05 .04 .05 .42 .06   
77 Right upper quadrant pain related to back pain .20 .46 .17 .06 .07 .09 -.04   
78 Right upper quadrant pain waking one up .16 .58 .16 .05 .09 .15 -.03   
80 Faecal incontinence .16 .10 .09 .14 .36 .10 -.03   
83 Anorectal pain .26 .15 .37 .13 .20 .05 .00   
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Supplementary table 3: Factor loadings in UK sample after varimax rotation. 
Item Topic C
o
n
st
ip
a
ti
o
n
 
U
p
p
e
r 
G
I 
A
b
d
o
m
in
a
l 
p
a
in
 
IB
S
 
D
ia
rr
h
o
e
a
 
V
o
m
it
in
g
 
N
a
u
se
a
 
H
e
a
rt
b
u
rn
 
A
b
d
o
m
in
a
l 
p
a
in
 I
I 
1 Lump in throat .18 .56 .03 .01 .10 -.04 -.02 -.02 .02 
3 Lump in throat when not eating .08 .14 .12 .07 .00 .03 .02 .11 .01 
4 Pain with swallowing .08 .35 .14 .05 .03 .18 .09 .20 .03 
5 Chest pain .21 .49 .05 -.04 .09 .14 .06 .07 .16 
7 Chest pain as burning sensation .03 .11 .15 .10 .03 .00 .00 .97 .01 
8 Chest pain and food sticking after swallowing .02 .44 .11 .17 .05 .05 .00 .27 -.16 
9 Heartburn .19 .40 .02 -.01 .14 .04 .07 .42 .15 
12 Foods stuck in chest .20 .68 .00 .05 .10 .05 .02 .11 .00 
14 Postprandial fullness .17 .52 .20 .08 .12 .18 .10 .02 .09 
16 Early satiety .20 .42 .22 .03 .13 .20 .13 .03 .07 
18 Epigastric pain/burning .15 .57 .22 .04 .10 .06 .22 .12 .26 
19 Epigastric pain/burning improved by defecation .11 .07 -.04 .44 -.01 .07 .05 .22 -.04 
21 Nausea .18 .40 .26 .02 .12 .19 .51 .01 .16 
23 Vomiting .10 .31 .11 .10 .08 .40 .39 .01 .10 
25 Self-induced vomiting .03 .03 -.10 .09 .09 .10 -.05 .07 .03 
32 Food coming back up after swallowing .16 .45 .04 .10 .13 .22 .25 .07 .08 
34 Retching .15 .19 .13 .10 .12 .68 .09 -.01 .00 
35 Vomiting when food comes back up .13 .19 .17 .07 .14 .79 .15 -.02 .06 
37 Food coming back up is recognisable .04 .10 .09 .13 .00 .13 .09 .01 .04 
38 Belching .07 .40 .20 .07 .15 .08 .30 .02 .11 
40 Pain anywhere in the abdomen .28 .29 .23 .09 .24 .09 .03 .01 .68 
41 Abdominal pain related to defecation .12 -.01 .05 .75 .11 .02 -.04 -.03 .03 
42 Abdominal pain related to stool consistency .20 .07 .07 .80 .25 .05 -.03 -.01 .09 
43 Abdominal pain related to stool frequency .23 .08 .08 .73 .29 .09 .06 .03 .08 
45 Abdominal pain related to a meal .04 .16 .32 .36 .27 .13 .14 .08 .07 
46 Abdominal pain limits usual activities .11 .17 .54 .29 .17 .10 .21 .05 .12 
49 Hard stools .66 .11 .10 .14 -.02 .06 .05 .06 .02 
51 Infrequent stools .57 .10 .11 .08 -.01 .14 .05 -.01 .07 
52 Straining during bowel movements .82 .13 .08 .14 .01 .07 .06 .04 .09 
53 Incomplete bowel emptying .73 .09 .06 .14 .24 .10 .04 .08 .14 
54 Anorectal obstruction / blockage .83 .17 .13 .14 .14 .06 .03 .04 .07 
55 Manual manoeuvres to facilitate defecation .56 .17 .02 .05 .11 .00 .06 -.01 -.04 
59 Loose stools .10 .13 .07 .22 .70 .14 .02 .03 .11 
61 Loose stools following a meal .07 .08 .15 .22 .64 .04 .01 .06 -.04 
63 Urgency .19 .18 .16 .26 .62 .12 .08 -.01 .09 
65 Bloating / abdominal distension .39 .27 .19 .08 .27 -.08 .10 .05 .33 
68 Right upper quadrant pain .28 .32 .30 .07 .21 .11 .07 .07 .53 
69 Long-lasting right upper quadrant pain .15 .11 .74 .02 .02 .04 .08 .08 .14 
70 Right upper quadrant pain of steady severe level .15 .11 .83 .02 .12 .13 .05 .05 .00 
71 Right upper quadrant pain at different intervals -.06 -.21 -.16 .16 -.04 -.13 .03 -.01 -.02 
72 Right upper quadrant pain limits usual activities .11 .30 .58 .03 .14 .06 .29 -.04 .00 
73 Right upper quadrant pain related to defecation .15 .00 .08 .54 .13 .01 .08 -.05 -.02 
74 Right upper quadrant pain related to posture .22 .05 .08 .17 .06 -.02 .23 .08 -.10 
75 Right upper quadrant pain improved by medicine .02 .18 .01 -.05 .02 -.06 .10 .25 .00 
76 Right upper quadrant pain related to vomiting .14 .17 .27 .00 .11 .21 .62 .11 .00 
77 Right upper quadrant pain related to back pain .15 .23 .19 .10 .08 .09 .13 .02 .02 
78 Right upper quadrant pain waking one up .12 .26 .39 .04 .22 .15 .29 .00 .14 
80 Faecal incontinence .12 .15 -.02 .03 .44 .02 .15 .03 .14 
83 Anorectal pain .42 .24 .08 .09 .22 .00 .10 -.02 .21 
 
